Development of amitriptyline buccoadhesive tablets for management of pain in dental procedures

Drug Development and Industrial Pharmacy

Volumn 37, Issue 7, 2011, Pages 849-854

  Movassaghian, Sara ^a,b   Barzegar Jalali, Mohammad ^a,c   Alaeddini, Mojgan ^d   Hamedyazdan, Sanaz ^a   Afzalifar, Rose ^d   Zakeri Milani, Parvin ^a   Mohammadi, Ghobad ^a,e   Adibkia, Khosro ^a,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amitriptyline; bioadhesive polymers; buccal analgesia; in vivo study; mucoadhesive tablets

Indexed keywords

AMITRIPTYLINE; CARBOXYMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; SODIUM CHANNEL;

ADULT; ANALGESIC ACTIVITY; ARTICLE; BUCCOADHESIVE TABLET; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADSORPTION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; MUCOADHESION; NORMAL HUMAN; PHYSICAL CHEMISTRY; RANDOMIZED CONTROLLED TRIAL; TABLET; TOOTH PAIN; VISCOSITY;

ADHESIVENESS; ADMINISTRATION, BUCCAL; ADULT; AMITRIPTYLINE; ANALGESIA; ANALGESICS, NON-NARCOTIC; CARBOXYMETHYLCELLULOSE SODIUM; DENTISTRY, OPERATIVE; DOUBLE-BLIND METHOD; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEMALE; HARDNESS; HUMANS; METHYLCELLULOSE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; TABLETS; YOUNG ADULT;

EID: 79958755728     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.546403     Document Type: Article

References (36)

1. Burch JE, Ahmed O, Hullin RP, Mindham RH. (1988). Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges. Psychopharmacology (Berl), 94:197-205 (Pubitemid 18040695)
2. Matthews K, Eagles JM, Matthews CA. (1993). The use of antidepressant drugs in general practice. A questionnaire survey. Eur J Clin Pharmacol, 45:205-210 (Pubitemid 23290368)
3. Goldman RH, Stason WB, Park SK, Kim R, Mudgal S, Davis RB, Kaptchuk TJ. (2010). Low-dose amitriptyline for treatment of persistent arm pain due to repetitive use. Pain, 149:117-123
4. Khan OA, Majumdar S, Jones NS. (2002). Facial pain following sinonasal surgery or facial trauma. Clin Otolaryngol Allied Sci, 27:171-174 (Pubitemid 34779640)
5. Laird B, Colvin L, Fallon M. (2008). Management of cancer pain: basic principles and neuropathic cancer pain. Eur J Cancer, 44:1078-1082
6. McQuay HJ, Carroll D, Glynn CJ. (1993). Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia, 48:281-285 (Pubitemid 23135505)
7. McQuay HJ, Carroll D, Glynn CJ. (1992). Low dose amitriptyline in the treatment of chronic pain. Anaesthesia, 47:646-652
8. Fridrich P, Colvin HP, Zizza A, Wasan AD, Lukanich J, Lirk P, Saria A, Zernig G, Hamp T, Gerner P. (2007). Phase 1A safety assessment of intravenous amitriptyline. J Pain, 8:549-555 (Pubitemid 46994769)
9. Khan MA, Gerner P, Kuo Wang G. (2002). Amitriptyline for prolonged cutaneous analgesia in the rat. Anesthesiology, 96:109-116 (Pubitemid 34032490)
10. Gerner P, Mujtaba M, Sinnott CJ, Wang GK. (2001). Amitriptyline versus bupivacaine in rat sciatic nerve blockade. Anesthesiology, 94:661-667 (Pubitemid 32249627)
11. Güler N, Durmus E, Tuncer S. (2005). Long-term follow-up of patients with atypical facial pain treated with amitriptyline. N Y State Dent J, 71:38-42
12. Agarwal V, Mishra B. (1999). Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm, 25:701-709 (Pubitemid 29239399)
13. Harris D, Robinson JR. (1992). Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci, 81:1-10
14. Hosny EA, Elkheshen SA, Saleh SI. (2002). Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies. Boll Chim Farm, 141:210-217 (Pubitemid 34847368)
15. Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2003). Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int J Pharm, 264:1-14 (Pubitemid 37297629)
16. Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugs. Drug Dev Ind Pharm, 30:995-1004 (Pubitemid 39453051)
17. Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm, 30:985-993 (Pubitemid 39453050)
18. Philip AK, Srivastava M, Pathak K. (2009). Buccoadhesive gels of glibenclamide: a means for achieving enhanced bioavailability. Drug Deliv, 16:405-415
19. Rojanasakul Y, Wang LY, Bhat M, Glover DD, Malanga CJ, Ma JK. (1992). The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res, 9:1029-1034
20. Salamat-Miller N, Chittchang M, Johnston TP. (2005). The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev, 57:1666-1691 (Pubitemid 41443474)
21. Yamsani VV, Gannu R, Kolli C, Rao ME, Yamsani MR. (2007). Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharm, 57:185-197 (Pubitemid 46761982)
22. Alsarra IA, Alanazi FK, Mahrous GM, Abdel Rahman AA, Al Hezaimi KA. (2007). Clinical evaluation of novel buccoadhesive film containing ketorolac in dental and post-oral surgery pain management. Pharmazie, 62:773-778 (Pubitemid 47608026)
23. Hao J, Heng PW. (2003). Buccal delivery systems. Drug Dev Ind Pharm, 29:821-832 (Pubitemid 37203684)
24. Chary RB, Vani G, Rao YM. (1999). In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems. Drug Dev Ind Pharm, 25:685-690
25. Ikinci G, Capan Y, Senel S, Alaaddinoglu E, Dalkara T, Hincal AA. (2000). In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine. Pharmazie, 55:762-765
26. Parodi B, Russo E, Gatti P, Cafaggi S, Bignardi G. (1999). Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane. Drug Dev Ind Pharm, 25:289-295 (Pubitemid 29108675)
27. Williams RO 3rd, Sykora MA, Mahaguna V. (2001). Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets. AAPS Pharmscitech, 2:E8
28. Wu B, Chen Z, Wei X, Sun N, Lu Y, Wu W. (2007). Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic study. Eur J Pharm Biopharm, 67:707-714
29. Emami J, Varshosaz J, Saljoughain N. (2008). Development and evaluation of controlled-release buccoadhesive verapamil hydrochloride tablets. Daru, 16:60-69 (Pubitemid 351877012)
30. Dortun B, Ozer L, Uyanik N. (1998). Development and in vitro evaluation of a buccoadhesive pindolol tablet formulation. Drug Dev Ind Pharm, 24:281-288 (Pubitemid 28119247)
31. Mohammadi-Samani S, Bahri-Najafi R, Yousefi G. (2005). Formulation and in vitro evaluation of prednisolone buccoadhesive tablets. Farmaco, 60:339-344 (Pubitemid 40545950)
32. Bhat SR, Shivakumar HG. (2010). Bioadhesive controlled release clotrimazole vaginal tablets. Trop J Pharm Res, 9:339-346
33. Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol, 27:48-49
34. Sator-Katzenschlager SM, Scharbert G, Kress HG, Frickey N, Ellend A, Gleiss A, Kozek-Langenecker SA. (2005). Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr, 117:761-768 (Pubitemid 41806788)
35. Ghafourian T, Gafourian T, Safari A, Adibkia K, Parviz F, Nokhodchi A. (2007). A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling. J Pharm Sci, 96:3334-3351
36. Shayeda GR, Palem CR, Rao YM. (2009). Development of novel bioadhesive buccal formulation of diltiazem: in vitro and in vivo characterization. PDA J Pharm Sci Technol, 63:401-408